Search

Your search keyword '"Hudry E"' showing total 68 results

Search Constraints

Start Over You searched for: Author "Hudry E" Remove constraint Author: "Hudry E"
68 results on '"Hudry E"'

Search Results

6. Mechanical behaviour of aluminium foams for various deformation paths. Experiment and modelling

8. Abnormal Synaptic Morphology and Neuronal Ca2+-Homeostasis in Migraine Mutant Mice

9. Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer's disease

10. Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice

11. Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery.

12. An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain Vasculature.

13. VWA3A -derived ependyma promoter drives increased therapeutic protein secretion into the CSF.

14. Neuronally Derived Soluble Abeta Evokes Cell-Wide Astrocytic Calcium Dysregulation in Absence of Amyloid Plaques in Vivo .

15. Neurofilament light chain and dorsal root ganglia injury after adeno-associated virus 9 gene therapy in nonhuman primates.

16. APOE4 derived from astrocytes leads to blood-brain barrier impairment.

17. Intrathecal sc-AAV9-CB-GFP: Systemic Distribution Predominates Following Single-Dose Administration in Cynomolgus Macaques.

18. Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer's disease.

19. Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3β) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation.

20. Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.

21. Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice.

22. Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer's disease.

23. Selection of an Efficient AAV Vector for Robust CNS Transgene Expression.

24. Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1.

25. Experimental evidence for the age dependence of tau protein spread in the brain.

26. The Major Risk Factors for Alzheimer's Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques.

28. Opposing Roles of apolipoprotein E in aging and neurodegeneration.

29. Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain.

30. Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery.

31. A flow cytometry-based in vitro assay reveals that formation of apolipoprotein E (ApoE)-amyloid beta complexes depends on ApoE isoform and cell type.

32. Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65.

33. In Vivo Two Photon Imaging of Astrocytic Structure and Function in Alzheimer's Disease.

34. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation.

35. Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.

36. Isoform- and cell type-specific structure of apolipoprotein E lipoparticles as revealed by a novel Forster resonance energy transfer assay.

37. Neuronal Cholesterol Accumulation Induced by Cyp46a1 Down-Regulation in Mouse Hippocampus Disrupts Brain Lipid Homeostasis.

38. Viral vectors for therapy of neurologic diseases.

39. Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain.

41. Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells.

42. Tailored transgene expression to specific cell types in the central nervous system after peripheral injection with AAV9.

43. Topological analyses in APP/PS1 mice reveal that astrocytes do not migrate to amyloid-β plaques.

44. Massachusetts Alzheimer's Disease Research Center: progress and challenges.

45. Abnormal synaptic Ca(2+) homeostasis and morphology in cortical neurons of familial hemiplegic migraine type 1 mutant mice.

46. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.

47. A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid β in the brain in a transgenic model of Alzheimer disease.

48. Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of Aβ amyloidosis.

49. RNA aptamer probes as optical imaging agents for the detection of amyloid plaques.

50. Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain.

Catalog

Books, media, physical & digital resources